Search results
American diets have a long way to go to achieve he | Newswise
Newswise· 7 days agoPoor diet continues to take a toll on American adults. It’s a major risk factor for obesity, type 2...
Roche partners with RNA editing biotech Ascidian
BioPharma Dive via Yahoo Finance· 12 hours agoWhile the Swiss pharma recently pruned its neurology drug pipeline, it has shown interest in the possibilities of RNA-focused approaches like what...
FDA approves generic Emflaza oral suspension for Duchenne muscular dystrophy
Medical Xpress· 1 day agoThe U.S. Food and Drug Administration has approved the first generic version of Emflaza...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
Bankrate via Yahoo Finance· 6 days agoHowever, investors should remain cautious. The full impact of donanemab on the Alzheimer’s treatment...
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 4 days agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 6 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Syntis Bio launches oral therapies for metabolic diseases
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe company's lead obesity programme, SYNT-101, is currently undergoing human...other rare disease...
Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening
Charlotte Observer via Yahoo Finance· 5 days agoAbout Eli Lilly Eli Lilly is known for producing obesity and diabetes drugs, including Jardiance,...
Weight loss injectables popularity steadily increase
WYMT Eastern Kentucky· 2 days agoIn March of 2024, the Food and Drug Administration approved injectables containing semaglutide to be used for weight ...
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an...
Benzinga· 2 hours agoErnst & Young LLP (EY US) today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, was named an Entrepreneur Of The Year® 2024 Pacific ...
